ESMOLOL CONCENTRATE Russian patent published in 2013 - IPC A61K9/00 A61K47/12 A61K31/215 A61K31/24 

FIELD: medicine, pharmaceutics.

SUBSTANCE: claimed is composition of esmolol in form of concentrated solution, which includes: a) from 40 to 60 mg/ml of esmolol hydrochloride; b) from 0.01 to 2 m of buffer agent; where value of solutions pH is in the interval from 4.0 to 6.0. Solution is free from agent, which regulates osmotic pressure. Solution is sterile, ready for application and packed into container. Claimed composition of esmolol is safer in comparison with the ones used at present time, which makes it possible for attending doctor to select volume of shock dose for direct injection to patient in more flexible way. Claimed is medical product, which includes concentrated esmolol solution, placed into container, and package, which contains container and application instruction.

EFFECT: application of esmolol composition by invention ensures reduction of possible negative for health consequences resulting from wrong dosage of esmolol concentrate compositions of previous level.

9 cl, 3 tbl, 1 ex